Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Mylan NV (MYL)

Mylan NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MYL
DateTimeSourceHeadlineSymbolCompany
06/05/202221:43Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:MYLMylan NV
29/09/202111:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MYLMylan NV
28/09/202114:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MYLMylan NV
10/09/202122:02Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MYLMylan NV
27/11/202022:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)NASDAQ:MYLMylan NV
19/11/202022:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
16/11/202021:03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MYLMylan NV
06/11/202014:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYLMylan NV
06/11/202013:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
06/11/202011:59PR Newswire (US)Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.NASDAQ:MYLMylan NV
02/11/202012:30PR Newswire (US)Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for ViatrisNASDAQ:MYLMylan NV
30/10/202018:23Dow Jones NewsPfizer, Mylan Agreement With FTC Over Upjohn Deal, Clearing Way for November ClosingNASDAQ:MYLMylan NV
30/10/202017:39PR Newswire (US)Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
30/10/202017:22Business WireMylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
15/09/202012:15PR Newswire (US)Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mLNASDAQ:MYLMylan NV
15/09/202012:00PR Newswire (US)Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
11/09/202022:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
09/09/202018:07PR Newswire (US)Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare ConferenceNASDAQ:MYLMylan NV
09/09/202018:05PR Newswire (US)Mylan to Present at the BofA Securities Virtual Global Healthcare ConferenceNASDAQ:MYLMylan NV
08/09/202007:00PR Newswire (US)Mylan to Acquire Aspen's Thrombosis Business in EuropeNASDAQ:MYLMylan NV
31/08/202011:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MYLMylan NV
31/08/202011:00PR Newswire (US)Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patien...NASDAQ:MYLMylan NV
28/08/202023:30PR Newswire (US)Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...NASDAQ:MYLMylan NV
19/08/202013:09Dow Jones NewsMylan Launches First U.S. Generic of Biogen MS Drug TecfideraNASDAQ:MYLMylan NV
19/08/202012:00PR Newswire (US)Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a Fi...NASDAQ:MYLMylan NV
12/08/202023:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MYLMylan NV
12/08/202014:00PR Newswire (US)Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19NASDAQ:MYLMylan NV
06/08/202022:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYLMylan NV
06/08/202013:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
06/08/202011:30PR Newswire (US)Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 GuidanceNASDAQ:MYLMylan NV
 Showing the most relevant articles for your search:NASDAQ:MYL